Direct-to-consumer misleading information on cancer risks calls for an urgent clarification of health genetic testing performed by commercial companies.

Adult Diagnostic Errors / prevention & control Direct-To-Consumer Screening and Testing / legislation & jurisprudence Drug Industry / legislation & jurisprudence Genetic Testing / legislation & jurisprudence Genome, Human Humans Incidental Findings Information Dissemination / ethics Male Neoplasms / diagnosis Risk Factors Sequence Analysis, DNA / standards
Direct-to-consumer testing Genetic counselling Medical genetics Medical practice Predictive medicine Whole genome sequencing

Journal

European journal of cancer (Oxford, England : 1990)
ISSN: 1879-0852
Titre abrégé: Eur J Cancer
Pays: England
ID NLM: 9005373

Informations de publication

Date de publication:
06 2020
Historique:
received: 28 02 2020
accepted: 04 03 2020
pubmed: 27 4 2020
medline: 11 11 2020
entrez: 27 4 2020
Statut: ppublish

Résumé

Direct-to-consumer (DTC) commercial companies offer genetic tests that are presented as allowing individuals the opportunity to increase their capacities to be in charge of their own healthcare managements. DTC companies deny performing medical tests, yet they provide data based on sequencing multigene panel or whole exome. This contradiction allows these companies to escape the requirements of a regulated medical practice that guarantees the quality of the tests, as well as the information and support for tested individuals. Herein, we illustrate the lack of such requirements by analysing the bad experience of a young man who dealt with DTC health genetic testing companies. There is an emergency for DTC testing to be either deprived of any medically relevant information, or carried out in a legally regulated medical framework.

Identifiants

DOI: 10.1016/j.ejca.2020.03.007 PMID: 32335476
pubmed: 32335476
pii: S0959-8049(20)30148-9
doi: 10.1016/j.ejca.2020.03.007
pii:
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

100-103

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of interest statement The authors declare that there is no conflict of interest.

Auteurs

Antoine de Pauw (A)

Department of Genetics, Institut Curie, Paris, France; Paris Sciences Lettres Research University, Paris, France.

Mathias Schwartz (M)

Department of Genetics, Institut Curie, Paris, France; Paris Sciences Lettres Research University, Paris, France.

Chrystelle Colas (C)

Department of Genetics, Institut Curie, Paris, France; Paris Sciences Lettres Research University, Paris, France.

Lisa Golmard (L)

Department of Genetics, Institut Curie, Paris, France; Paris Sciences Lettres Research University, Paris, France.

Dominique Stoppa-Lyonnet (D)

Department of Genetics, Institut Curie, Paris, France; INSERM U830, Institut Curie Paris, Paris, France; Paris-University, Paris, France. Electronic address: dominique.stoppalyonnet@curie.fr.

Articles similaires

Comprehensive comparative analysis and development of molecular markers for Lasianthus species based on complete chloroplast genome sequences.

Yue Zhang, Meifang Song, Deying Tang et al.
1.00
Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH

questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Direct-to-consumer misleading information on...
questionsmedicales.fr › Établissements, main d'oeuvre et services de soins de santé › Services de santé › Erreurs médicales › Erreurs de diagnostic › Direct-to-consumer misleading information on...
questionsmedicales.fr › Établissements, main d'oeuvre et services de soins de santé › Services de santé › Services de médecine préventive › Services de diagnostic › Dépistage et analyse proposés directement au consommateur › Direct-to-consumer misleading information on...
questionsmedicales.fr › Technologie, industrie et agriculture › Industrie › Secteur secondaire › Industrie pharmaceutique › Direct-to-consumer misleading information on...
questionsmedicales.fr › Établissements, main d'oeuvre et services de soins de santé › Services de santé › Services de médecine préventive › Services de diagnostic › Dépistage génétique › Direct-to-consumer misleading information on...
questionsmedicales.fr › Phénomènes génétiques › Structures génétiques › Génome › Génome humain › Direct-to-consumer misleading information on...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Direct-to-consumer misleading information on...
questionsmedicales.fr › Diagnostic › Résultats fortuits › Direct-to-consumer misleading information on...
questionsmedicales.fr › Sciences de l'information › Communication › Diffusion de l'information › Direct-to-consumer misleading information on...
questionsmedicales.fr › Tumeurs › Direct-to-consumer misleading information on...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Statistiques comme sujet › Probabilité › Risque › Facteurs de risque › Direct-to-consumer misleading information on...
questionsmedicales.fr › Techniques d'investigation › Techniques génétiques › Analyse de séquence › Analyse de séquence d'ADN › Direct-to-consumer misleading information on...